World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ANZCTR
Last refreshed on: 13 January 2020
Main ID:  ACTRN12614001191684
Date of registration: 12/11/2014
Prospective Registration: No
Primary sponsor: Mehmet Aksoy
Public title: The effects of positive end-expiratory pressure at different levels on postoperative respiration parameters in patients undergoing laparoscopic cholecystectomy
Scientific title: The effects of positive end-expiratory pressure at different levels (0, 5 and 8 cmH2O) on postoperative respiration parameters in patients undergoing laparoscopic cholecystectomy
Date of first enrolment: 10/06/2013
Target sample size: 84
Recruitment status: Completed
URL:  https://anzctr.org.au/ACTRN12614001191684.aspx
Study type:  Interventional
Study design:  Purpose: Treatment; Allocation: Randomised controlled trial; Masking: Blinded (masking used);Assignment: Parallel;Type of endpoint: Safety/efficacy;  
Phase:  Phase 3
Countries of recruitment
Turkey
Contacts
Name: Dr Mehmet Aksoy   
Address:  Department of Anaesthesiology and Reanimation, Faculty of Medicine, Vaniefendi district, Ataturk University, Erzurum, Turkey Postal code: 25240 Turkey
Telephone: +90 505 819 35 26
Email: drmaksoy@hotmail.com
Affiliation: 
Name: Dr Ilker Ince   
Address:  Department of Anaesthesiology and Reanimation, Faculty of Medicine, Vaniefendi district, Ataturk University, Erzurum, Turkey Postal code: 25240 Turkey
Telephone: +9 0507 243 75 47
Email: ilkerince1983@yahoo.com
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 105 consecutive patients, with American Society of Anesthesiologists (ASA) physical status I or II, aged 18-65 years undergoing elective laparoscopic cholecystectomy were included in this study
Exclusion criteria: Patients with ASA III-V physical status, smoking, body mass indexes (BMI) > 40 kg/m2, cardiorespiratory disease and unable to perform pulmonary function tests were excluded from the study

Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both males and females
Health Condition(s) or Problem(s) studied
Surgery - Other surgery
Respiratory - Normal development and function of the respiratory system
Anaesthesiology - Other anaesthesiology
postoperative respiration parameters following cholecystectomy;
postoperative respiration parameters following cholecystectomy
Intervention(s)
From June 2013 to March 2014, 105 consecutive patients undergoing elective laparoscopic cholecystectomy were included in this study. Preoperatively, physical examination of the patients was performed by an anaesthesiologist and all patients received detailed information about the respiratory function test and spirometry. Before the operation, respiratory function was evaluated using spirometry (Vitalograph micro. 63000 Series, Ennis, Ireland) by an anaesthesiologist blinded to the group assignment. Before entering the operating room, all patients received 500 mL of colloids via intravenous (IV) cannula and premedication was provided with intramuscular (im) 0.1 mg/kg midazolam for all patients before induction of anaesthesia. Standard monitoring including non-invasive arterial pressure, electrocardiography and pulse oximetry was established in the operating room. Before the operation, heart rate (HR), peripheral oxygen saturation (SpO2), systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) values were recorded. Patients were randomly allocated into one of the three groups after induction of general anaesthesia using a computer generated random number table. Group I (n=35) did not receive PEEP whereas group II (n=35) received PEEP as 5 cmH2O and group III received PEEP as 8 cm H2O in mechanical ventilation during laparoscopic procedure . Same anaesthesia protocol was applied for all patients. Anaesthesia induction was provided with IV 2. microg/kg fentanyl, IV 2mg/kg propofol and 0.5-1 mg/kg rocuronium. All patients received colloids at a rate of 3-5 ml/kg/h during operation. Tracheal intubation was performed and anaesthesia was maintained with sevoflurane 1-2%, air (50%), oxygen (50%) and remifentanyl infusion at a rate of 0.15-0.25
Primary Outcome(s)
to evaluate postoperative respiration parameters including forced expiratory volume (FEV1), forced vital capacity (FVC) and peak expiratory flow (PEF) using spirometer in patients undergoing laparoscopic cholecystectomy following the 0, 5 and 8 cmH2O PEEP applications. [Timepoint:1 hour before the operation (T1) and, 1 (T2), 6 (T3) and 24 hours (T4) after extubation]
Secondary Outcome(s)
to evaluate mean arterial pressure (MAP) values using standard monitorization in patients undergoing laparoscopic cholecystectomy following the 0, 5 and 8 cmH2O PEEP applications. [1 hour before the operation (T1) and, 1 (T2), 6 (T3) and 24 hours (T4) after extubation]
to evaluate peripheral oxygen saturation (SpO2) changes using pulse oximetry in patients undergoing laparoscopic cholecystectomy following the 0, 5 and 8 cmH2O PEEP applications.[1 hour before the operation (T1) and, 1 (T2), 6 (T3) and 24 hours (T4) after extubation]
to evaluate postoperative heart rate (HR) changes using electrocardiography in patients undergoing laparoscopic cholecystectomy following the 0, 5 and 8 cmH2O PEEP applications. [1 hour before the operation (T1) and, 1 (T2), 6 (T3) and 24 hours (T4) after extubation]
Secondary ID(s)
None
Source(s) of Monetary Support
Dr. Mehmet AKSOY
Secondary Sponsor(s)
Bahadir Ciftci
Ilker Ince
Ethics review
Status: Approved
Approval date:
Contact:
Ataturk University Medical Faculty Ethical Committee, Erzurum,Turkey
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history